1. Home
  2. VCYT vs IPAR Comparison

VCYT vs IPAR Comparison

Compare VCYT & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • IPAR
  • Stock Information
  • Founded
  • VCYT 2006
  • IPAR 1982
  • Country
  • VCYT United States
  • IPAR United States
  • Employees
  • VCYT N/A
  • IPAR N/A
  • Industry
  • VCYT Medical Specialities
  • IPAR Package Goods/Cosmetics
  • Sector
  • VCYT Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • VCYT Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • VCYT 2.9B
  • IPAR 2.6B
  • IPO Year
  • VCYT 2013
  • IPAR 1988
  • Fundamental
  • Price
  • VCYT $48.53
  • IPAR $80.93
  • Analyst Decision
  • VCYT Buy
  • IPAR Strong Buy
  • Analyst Count
  • VCYT 9
  • IPAR 5
  • Target Price
  • VCYT $43.56
  • IPAR $128.20
  • AVG Volume (30 Days)
  • VCYT 1.2M
  • IPAR 290.9K
  • Earning Date
  • VCYT 11-04-2025
  • IPAR 11-05-2025
  • Dividend Yield
  • VCYT N/A
  • IPAR 3.95%
  • EPS Growth
  • VCYT N/A
  • IPAR 9.68
  • EPS
  • VCYT 0.38
  • IPAR 5.13
  • Revenue
  • VCYT $495,141,000.00
  • IPAR $1,463,838,000.00
  • Revenue This Year
  • VCYT $14.52
  • IPAR $4.04
  • Revenue Next Year
  • VCYT $9.90
  • IPAR $5.16
  • P/E Ratio
  • VCYT $125.41
  • IPAR $15.79
  • Revenue Growth
  • VCYT 16.41
  • IPAR 3.12
  • 52 Week Low
  • VCYT $22.61
  • IPAR $77.21
  • 52 Week High
  • VCYT $50.71
  • IPAR $148.15
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 71.15
  • IPAR 31.81
  • Support Level
  • VCYT $37.98
  • IPAR $79.37
  • Resistance Level
  • VCYT $50.71
  • IPAR $82.36
  • Average True Range (ATR)
  • VCYT 2.11
  • IPAR 2.98
  • MACD
  • VCYT 0.73
  • IPAR -0.28
  • Stochastic Oscillator
  • VCYT 82.09
  • IPAR 29.47

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: